Autopsy report · NCT04957602

Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)

“funding ending”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 4 months before it stopped.
• 6 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Hospices Civils de Lyon

Sponsor type

University, hospital or other

Conditions

Non Small Cell Lung Cancer

Interventions

Blood collection

Participants

6

Sites

1

Countries

France

Trials that died the same way

• Gas Supply, Demand and Middle Ear Gas Balance -- Diagnosis of Eustachian Tube Dysfunction
  “End of funding” (94% match in meaning)
• MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma
  “Funding ended” (91% match in meaning)
• Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients
  “Funding ended prematurely” (85% match in meaning)
• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
  “Funding Termination” (85% match in meaning)
• Insulin Resistance Following ADT for Prostate CA
  “End of grant funding” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.